Japan Fukuoka SOUSEIKAI Hospital and Yonsei University Severance Hospital have concluded Memorandum of Understanding concerning medical device joint clinical trials and have decided to conduct clinical trials of Anyfusion Cylinder pump as the first target.

In Japan, TERUMO, the world's top five major drug infusion pumps, sells more than 600 billion won a year, and the country has a company that sells existing drug infusion pumps on a large scale, such as NIPPRO and TOP. As a representative of SOUSEIKAI Hospital, I heard the benefits of the world's first Cylinder pump and decided to do it soon.

Similar to the test results conducted by Seoul National University and Incheon Gil Hospital, if Anyfusion proves its superiority in Japan, it can be expected to have a good business outcome by positively influencing business entering global market and business with global major.

From October 31 to November 1, clinical trial participants will be presented with product descriptions and presentations, and the meeting will begin on November 2. If it is proven that Anyfusion is excellently tested through clinical trials in a developed country with a global company, it will have a big impact on global marketing.

I would like to thank Yonsei University Hospital and Umt for your hard work.